ArticleJournal of maxillofacial and oral surgery2025
Tale of Ameloblastoma - An Experience Spanning Two Decades.
Article in Journal of maxillofacial and oral surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite being a benign pathology, ameloblastoma is considered to be locally-aggressive and has a high recurrence-rate. The following study describes the experience in a tertiary care hospital to manage ameloblastoma using treatment modalities based on the site of occurrence and histologic-type and to evaluate recurrence in long term. Material and methods: In this 21-year-long retrospective study, 92 patients were followed-up for a minimum period of 5-years (range 5-21 years) to assess the clinical and demographic characteristics, treatment-procedure performed, and outcomes including the recurrence-rate associated with different treatment-strategies for treating ameloblastoma. Results: Out of 92 cases, 90 had mandibular involvement, with the most frequent site being Body (B), and Angle and Ramus (AR) region. The most prevalent histological-subtype was plexiform ameloblastoma. Five cases had mixed histopathologic-presentations in which more than one histological variant was found simultaneously. Segmental resection with reconstruction using a reconstruction plate was the most commonly employed surgical procedure for all histologic types. One case of plexiform ameloblastoma that underwent marginal resection presented with a recurrence at 189 months. Conclusions: Based on the observed results, it is concluded that adequate surgical planning along with long-term follow-up may provide the desired results and reduce the rate of recurrence. Supplementary Information: The online version contains supplementary material available at 10.1007/s12663-024-02197-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.